跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAYVIGO lemborexant 5 mg film coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
DAYVIGO lemborexant 5 mg film coated tablet blister pack
Approved
STANDARD
DAYVIGO lemborexant 5 mg film coated tablet blister pack
Eisai Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
98c3ea2d8c98b778
Company
Eisai Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
98c3ea2d8c98b778
Product Name
DAYVIGO lemborexant 5 mg film coated tablet blister pack
Artg Id
338631
Artg Name
DAYVIGO lemborexant 5 mg film coated tablet blister pack
Sponsor
Eisai Australia Pty Ltd
Company Detail Path
/organization/eisai-australia-pty-ltd
Artg Date
2021-07-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/20465d5f24b741ab2d7170a0972dd498.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/33ac601d534ee6f63aae3a24e4cc7d3d.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
98c3ea2d8c98b778
Type
Standard
Back to TGA Approvals